Detalles de la búsqueda
1.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612799
2.
Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination.
Future Oncol
; 18(23): 2537-2550, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678621
3.
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes.
Biomedicines
; 12(3)2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38540148
4.
Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer.
Lancet Reg Health Eur
; 38: 100839, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476751
5.
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries.
Lancet Reg Health Eur
; 38: 100838, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476742
6.
A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers.
Vaccines (Basel)
; 11(6)2023 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37376406
7.
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis.
Radiol Oncol
; 57(3): 397-404, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37665737
8.
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Ther Adv Med Oncol
; 14: 17588359221103206, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35720834
9.
Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19.
ERJ Open Res
; 8(4)2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36474964
10.
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
Ther Adv Med Oncol
; 13: 17588359211019675, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34178121
11.
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study.
Transl Lung Cancer Res
; 10(4): 1594-1607, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34012777
12.
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Clin Cancer Res
; 26(14): 3819-3830, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32317288
13.
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial.
J Thorac Oncol
; 15(10): 1647-1656, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32565388
14.
Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
Cells
; 8(9)2019 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527449
15.
Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis.
Chest
; 132(4): 1291-7, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17646229
16.
Highly efficient automated extraction of DNA from old and contemporary skeletal remains.
J Forensic Leg Med
; 37: 78-86, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26615474
Resultados
1 -
16
de 16
1
Próxima >
>>